FBIO Fortress Biotech, Inc.
Healthcare$2.69-1.82%ClosedMarket Cap: $89.4M
As of 2026-05-26
Valuation
P/E (TTM)
11.10
PEG
0.10
P/B
0.53
P/S
1.38
EV/EBITDA
20.64
DCF Value
$-0.81
FCF Yield
173.2%
Div Yield
0.0%
Margins & Returns
Gross Margin
64.5%
Operating Margin
-84.4%
Net Margin
193.1%
ROE
163.9%
ROA
35.8%
ROIC
-20.9%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $16.0M | 54.2% | $-7.7M | $110.4M | $— | — |
| Q4 null | $16.1M | 66.2% | $-4.8M | $-3.9M | $— | — |
| FY null | $63.3M | 66.9% | $-70.2M | $6.8M | $— | — |
| Q3 null | $17.6M | 67.4% | $-6.8M | $5.8M | $— | — |
| Q2 null | $16.4M | 69.9% | $-36.5M | $15.5M | $— | — |
| Q1 null | $13.1M | 63.5% | $-22.3M | $-10.6M | $— | — |
| Q4 null | $15.1M | 61.6% | $-27.3M | $-6.8M | $— | — |
| FY null | $57.7M | 63.8% | $-110.4M | $-46.0M | $— | — |
| Q3 null | $14.6M | 63.9% | $-22.1M | $-12.9M | $— | — |
| Q2 null | $14.9M | 56.1% | $-27.8M | $-10.9M | $— | — |
| Q1 null | $13.0M | 53.9% | $-36.6M | $-15.4M | $— | — |
| Q4 2023 | $19.9M | 69.8% | $-19.6M | $-9.3M | $-1.19 | — |